Why you won’t see this medication anytime soon
“Merck & Co. Inc.’s painkiller Arcoxia offers a “marginal” advantage in gastrointestinal safety but appears “worse than” other pain drugs as well as a placebo in terms of deaths and serious cardiovascular problems, U.S. regulatory staff said in documents released on Friday.”
Merck had hoped that Arcoxia would be their next generation COX-2 medication. I don’t think so.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
